Needham & Company Cuts Numbers on Hi Tech Pharmacal (HITK) After Latest Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Hi-Tech Pharmacal Co. (HITK) Misses Q4 EPS by 13c, Sales Light
July 9, 2013 7:23 AM EDTHi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q4 EPS of $0.50, $0.13 worse than the analyst estimate of $0.63. Revenue for the quarter came in at $58.5 million versus the consensus estimate of $66.33 million.
David Seltzer, President and CEO, commented: "The Company showed growth while facing several... More
